The California-based company offers a patent-pending network analysis engine that identifies treatment options based on bio-markers, proteins, genes, pathways, and specific molecules. Kuveda's platform combines curated repositories daily to provide oncologists with comprehensive reports, including patient-specific drug regiment options, supporting evidence and insights, individual patient biology, patient history, and toxicology considerations. As a part of the StartUp Health Academy, Kuveda has a global peer network of healthcare innovators in seven countries and 45 cities. Their vision is to deliver cancer therapeutics on a personalized basis to enhance patients' quality of life and survival rate, and their mission is to be the premier provider of SaaS tools and services for effective personalized therapeutic cancer treatments based on molecular analysis.